In summary, our study confirms that a high risk screening strategy where only women in the high risk group are tested would miss the majority of thyroid disorders in pregnant women. We believe universal screening of sTSH, FT4, and TPOAb is essential during the first trimester and second trimester of pregnancy. Taken together, we support implementation of a universal screening strategy for thyroid disorders in pregnant women
